Tonix Pharmaceuticals Q1 2026 Earnings WiderThanExpected Loss Compounds Investor Concerns AERT Q1 2026 Earnings A Modest Profit Amidst Limited Disclosure MLYS Q1 2026 Earnings EPS In Line with Estimates No Revenue Yet SUPV Q1 2026 Earnings Stunning EPS Beat of 270 Amid Operational Turnaround ASRT Q1 2026 Earnings Significant EPS Miss Amid Revenue Disclosure Absence TREX Q1 2026 Earnings Strong Earnings Beat Drives Stock Higher